Article Versions Notes

Martí C, Yébenes L, Oliver JM, Moreno E, Frías L, Berjón A, Loayza A, Meléndez M, Roca MJ, Córdoba V, et al. The Clinical Impact of Neoadjuvant Endocrine Treatment on Luminal-like Breast Cancers and Its Prognostic Significance: Results from a Single-Institution Prospective Cohort Study. Current Oncology. 2022; 29(4):2199-2210. https://doi.org/10.3390/curroncol29040179

Martí, Covadonga, Laura Yébenes, José María Oliver, Elisa Moreno, Laura Frías, Alberto Berjón, Adolfo Loayza, Marcos Meléndez, María José Roca, Vicenta Córdoba, and et al. 2022. "The Clinical Impact of Neoadjuvant Endocrine Treatment on Luminal-like Breast Cancers and Its Prognostic Significance: Results from a Single-Institution Prospective Cohort Study" Current Oncology 29, no. 4: 2199-2210. https://doi.org/10.3390/curroncol29040179

Martí, C., Yébenes, L., Oliver, J. M., Moreno, E., Frías, L., Berjón, A., Loayza, A., Meléndez, M., Roca, M. J., Córdoba, V., Hardisson, D., Rodríguez, M. Á., & Sánchez-Méndez, J. I. (2022). The Clinical Impact of Neoadjuvant Endocrine Treatment on Luminal-like Breast Cancers and Its Prognostic Significance: Results from a Single-Institution Prospective Cohort Study. Current Oncology, 29(4), 2199-2210. https://doi.org/10.3390/curroncol29040179